Sclerosing Adenosis: Risks, Diagnosis, and Treatment Options - Surgery

More Info

---

Sclerosing adenosis is a benign breast condition characterized by the proliferation of glandular and fibrous tissue in the breast. It is often discovered incidentally during imaging studies, such as mammograms or ultrasounds, and can sometimes be associated with calcifications. While sclerosing adenosis itself is not cancerous, it can be a risk factor for developing breast cancer, particularly if there are other risk factors present.

In your case, it seems that you have already undergone surgery to remove a lump that was diagnosed as sclerosing adenosis. The presence of calcifications noted on imaging studies, as well as the decision to monitor rather than immediately operate, indicates that your healthcare team was following standard protocols for managing such findings. The fact that you have undergone surgery and the lump has been removed is a positive step, but it is understandable to be concerned about the potential for future breast cancer, especially given the history of sclerosing adenosis.

Regarding your question about the risk of developing in situ carcinoma after having sclerosing adenosis, it is important to note that while sclerosing adenosis itself is not cancer, it can be associated with an increased risk of breast cancer. The degree of risk can depend on various factors, including family history, genetic predispositions, and the presence of other breast conditions. Regular follow-up with your healthcare provider is essential to monitor any changes in your breast tissue.

As for the new lumps you mentioned in both breasts, it is advisable to have these evaluated further. A needle biopsy (fine needle aspiration or core needle biopsy) can provide more information about the nature of these lumps. This procedure is generally minimally invasive and can help determine whether the lumps are benign or require further intervention. Micro-invasive techniques are often suitable for lumps under one centimeter, and the risk of causing a noticeable indentation or deformity in the breast is typically low, especially when performed by an experienced surgeon.

In terms of follow-up, it is common practice to monitor breast conditions like sclerosing adenosis with regular imaging studies, often every six months to a year, depending on individual circumstances. If there are changes in the size or characteristics of the lumps, or if new symptoms arise, more frequent follow-up may be warranted.

In summary, while you have taken proactive steps by having the lump removed, it is crucial to maintain open communication with your healthcare team regarding the new lumps and any concerns you may have. Regular monitoring, appropriate imaging, and possibly biopsies will help ensure that any changes in your breast tissue are addressed promptly. If you feel uncertain or anxious about your situation, consider seeking a second opinion or discussing your concerns with a breast specialist who can provide tailored advice based on your specific circumstances. Remember, early detection and intervention are key in managing breast health effectively.